A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) | MicrobiomeTrials
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-05-28Est. Completion: 2029-01
Enrollment target: 30 participants
Locations
UCLA Health West Medical Campus /ID# 282811, Los Angeles, California, United States
Solace Research /ID# 279155, Tustin, California, United States
Finlay Medical Research - Greenacres /ID# 278380, Greenacres City, Florida, United States
Discovery Health Research Center /ID# 279691, Plantation, Florida, United States
Epic Medical Research /ID# 279180, Red Oak, Texas, United States